Michael Burry bets on Regeneron recovery despite market skepticism, holds large call positions in UnitedHealth Group, and views Lululemon as undervalued.
2 reports, 1 independent
Updated Sep 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael Burry bets on Regeneron recovery despite market skepticism, holds large call positions in UnitedHealth Group, and views Lululemon as undervalued.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Michael Burry
American hedge fund manager
-
Regeneron Pharmaceuticals
American pharmaceutical company
-
UnitedHealth Group
for-profit health care company
-
Lululemon Athletica
Canadian athletic apparel retailer